$VTGN hypothetical Buyout 👀 🔹 If Vistagen’s data hits clean, big pharma could start circling fast 🚀 🔹 Potential suitors? JNJ, AbbVie, Otsuka, Lundbeck, BMY

$VTGN hypothetical Buyout 👀 🔹 If Vistagen’s data hits clean, big pharma could start circling fast 🚀 🔹 Potential suitors? JNJ, AbbVie, Otsuka, Lundbeck, BMY, Biogen, Pfizer — all logical CNS players 🧠 🔹 A strong Phase 3 win in social anxiety could make fasedienol a highly differentiated asset …